MedPAC mulls financial relationship disclosure rules

The Medicare Payment Advisory Commission (MedPAC)  has begun considering recommendations that would require new disclosures regarding financial relationships between drug manufacturers, device makers, physicians and other providers. The recommendations are a sign of the times, as they come on the heels of a growing series of legal decisions, regulations and laws expanding such disclosure rules.

One recommendation would establish a new federal law requiring all makers of drugs, biologicals, medical devices, and suppliers and their subsidiaries to submit data on their financial relationships with various providers. This would include physicians and other prescribers, hospitals and medical schools, professional and patient-safety groups and organizations sponsoring CME programs.

Other proposed recommendations would require hospitals and ambulatory surgery centers to report every year on each physician who directly or indirectly owns an interest in an ASC. Also, HHS would submit a report on the prevalence of financial relationships between hospitals and physicians.

To learn more about MedPAC's ideas:
- read this Modern Healthcare piece (reg. req.)

Related Articles:
Congress debates pharma gift disclosure
NJ mulls pharma, device maker gift reporting
NY bill would require pharmas to report MD gifts
Reader feedback: Is limiting industry gifts a smart policy?

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Nominations are open for our 2020 FierceHealthcare Fierce 15 awards. Think your company has what it takes? Submit your nominations here.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options.